(Q48264764)

10 February 2018

title

Gender-related differences in the burden of non-motor symptoms in Parkinson's disease (English)

1 reference

10 February 2018

1 reference

5

1 reference

10 February 2018

Dag Aarsland

9

1 reference

10 February 2018

David J. Brooks

10

1 reference

10 February 2018

Kallol Ray Chaudhuri

11

1 reference

10 February 2018

Claudia Trenkwalder

8

object named as

Claudia Trenkwalder

1 reference

10 February 2018

Pablo Martinez-Martin

1

object named as

Pablo Martinez-Martin

1 reference

10 February 2018

3

Per Odin

1 reference

10 February 2018

author name string

Cristian Falup Pecurariu

2

1 reference

10 February 2018

Jacobus J van Hilten

4

1 reference

10 February 2018

Jose M Rojo-Abuin

6

1 reference

10 February 2018

Vanderci Borges

7

1 reference

10 February 2018

publication date

12 January 2012

1 reference

10 February 2018

published in

Journal of Neurology

1 reference

10 February 2018

volume

259

1 reference

10 February 2018

issue

8

1 reference

10 February 2018

page(s)

1639-1647

1 reference

10 February 2018

https://scigraph.springernature.com/pub.10.1007/s00415-011-6392-3

exact match

0 references

cites work

The non-motor symptom complex of Parkinson's disease: a comprehensive assessment is essential

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6392-3

Sydney Multicenter Study of Parkinson's disease: non-L-dopa-responsive problems dominate at 15 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6392-3

Non-motor symptoms of Parkinson's disease: diagnosis and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6392-3

Prevalence of nonmotor symptoms in Parkinson's disease in an international setting; study using nonmotor symptoms questionnaire in 545 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6392-3

Non-recognition of depression and other non-motor symptoms in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6392-3

The nondeclaration of nonmotor symptoms of Parkinson's disease to health care professionals: an international study using the nonmotor symptoms questionnaire

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6392-3

Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6392-3

International study on the psychometric attributes of the non-motor symptoms scale in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6392-3

The metric properties of a novel non-motor symptoms scale for Parkinson's disease: Results from an international pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6392-3

Gender differences in Parkinson's disease symptom profile.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6392-3

Incidence of Parkinson's disease: variation by age, gender, and race/ethnicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6392-3

Gender and the Parkinson's disease phenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6392-3

Subthreshold depression in patients with Parkinson's disease and dementia--clinical and demographic correlates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6392-3

Assessment of sexual dysfunction in patients with Parkinson's disease: a case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6392-3

Sex and gender in older adults' experience of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6392-3

Gender differences in Parkinson's disease: clinical characteristics and cognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6392-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6392-3

Parkinsonism: onset, progression, and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6392-3

A short scale for the assessment of motor impairments and disabilities in Parkinson's disease: the SPES/SCOPA

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6392-3

The Clinical Impression of Severity Index for Parkinson's Disease: international validation study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6392-3

EuroQol--a new facility for the measurement of health-related quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6392-3

Fatigue in Parkinson's disease: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6392-3

The PRIAMO study: A multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6392-3

Fatigue in Parkinson's disease: prevalence and associated factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6392-3

Parkinson's disease: the quintessential neuropsychiatric disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6392-3

Emotional dysfunction in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6392-3

Parkinson disease: Depression and anxiety in Parkinson disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6392-3

Symptomatology and markers of anxiety disorders in Parkinson's disease: a cross-sectional study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6392-3

Determinants of quality of life in Brazilian patients with Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6392-3

Prevalence and correlates of neuropsychiatric symptoms in Parkinson's disease without dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6392-3

A systematic review of prevalence studies of depression in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6392-3

Depression in Parkinson's disease: clinical correlates and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6392-3

Constipation and its management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6392-3

Pain in Parkinson's disease: Prevalence and characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6392-3

Spontaneous pain, pain threshold, and pain tolerance in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6392-3

Pain is common in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6392-3

Restless legs syndrome in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6392-3

Restless legs syndrome in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6392-3

Prevalence and clinical profile of restless legs syndrome in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6392-3

Daytime sleepiness and other sleep disorders in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6392-3

Excessive daytime sleepiness in Parkinson disease: is it the drugs or the disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6392-3

Sleep quality in Parkinson disease: an examination of clinical variables

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6392-3

Sialorrhoea and drooling in patients with Parkinson's disease: epidemiology and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6392-3

Autonomic dysfunction in 3414 Parkinson's disease patients enrolled in the German Network on Parkinson's disease (KNP e.V.): the effect of ageing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6392-3

'We call it the shaking illness': perceptions and experiences of Parkinson's disease in rural northern Tanzania

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6392-3

Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6392-3

Estrogen actions in the brain and the basis for differential action in men and women: a case for sex-specific medicines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6392-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6392-3

Generalized anxiety disorder in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6392-3

Generalised anxiety disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6392-3

Prevalence and predictors of depression in populations of elderly: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6392-3

Onset of anxiety and depression in the aging population: comparison of risk factors in a 9-year prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6392-3

Generalised musculoskeletal pain syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6392-3

Defining gender disparities in pain management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6392-3

Gender differences in sleep disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6392-3

Intrajejunal levodopa infusion in Parkinson's disease: a pilot multicenter study of effects on nonmotor symptoms and quality of life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6392-3

Gender differences in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6392-3

Anxiety disorders in Parkinson's disease.

21 January 2018

1 reference

12 December 2020

Impact of fatigue in Parkinson's disease: the Fatigue Impact Scale for Daily Use (D-FIS)

1 reference

12 December 2020

Anxiety disorders in patients with Parkinson's disease

1 reference

12 December 2020

Clinical aspects of bowel symptoms in Parkinson's disease

1 reference

12 December 2020

Pain in Parkinson's disease

1 reference

12 December 2020

1 reference

12 December 2020

Fatigue in Parkinson's disease

1 reference

12 December 2020

The epidemiology of fatigue and depression: a French primary-care study

1 reference

12 December 2020

Gender differences in Parkinson's disease

1 reference

12 December 2020

Do nonmotor symptoms in Parkinson's disease differ from normal aging?

1 reference

12 December 2020

The SCOPA-Motor Scale for assessment of Parkinson's disease is a consistent and valid measure

1 reference

12 December 2020

Global versus factor-related impression of severity in Parkinson's disease: A new clinimetric index (CISI-PD)

1 reference

12 December 2020

Restless legs syndrome: a comprehensive overview on its epidemiology, risk factors, and treatment

1 reference

12 December 2020

10.1007/S00415-011-6392-3

Identifiers

DOI

1 reference

10 February 2018

release_7u7zc55pobbljh4z3cjdw2ydnu

Fatcat ID

0 references

1 reference

10 February 2018